NBTXR3-mediated radiotherapy not only leads to enhanced direct tumor destruction (29–31), but also can activate the cGAS-STING pathway in cancer cells (32), improve the immunogenic cell death and modulate the immunopeptidome for promoting antitumor immunity (33). The gene discussed is STING1; the disease is neoplasm.